Fig. 1.

Fig. 2.

Agreement in eGFR-based CKD staging between enzymatic and Jaffe methods using CKD-EPI and EKFC equations, assessed by weighted kappa and Kendall’s tau, stratified by sex_
| Equation | Male patients | Female patients | ||
|---|---|---|---|---|
| Weighted Kappa | Kendall’s Tau | Weighted Kappa | Kendall’s Tau | |
| CKD-EPI | 0.928 (CI: 0.900–0.956) | 0.949 | 0.923 (CI: 0.894–0.951) | 0.943 |
| EKFC | 0.916 (CI: 0.885–0.947) | 0.95 | 0.943 (CI: 0.918–0.969) | 0.959 |
Multiple linear regression models for ΔeGFR by sex and eGFR equation (CKD-EPI, EKFC), with SCr (enzymatic, Jaffe) and age as predictors_
| Sex | Equation | Predictor | B | p |
|---|---|---|---|---|
| Male | ΔeGFRCKD-EPI | SCrEnz | −11.579 | <0.001 |
| SCrJaffe | 11.17 | <0.001 | ||
| Age | 0.005 | 0.756 | ||
| ΔeGFREKFC | SCrEnz | −11.042 | <0.001 | |
| SCrJaffe | 10.667 | <0.001 | ||
| Age | 0.004 | 0.783 | ||
| Female | ΔeGFRCKD-EPI | SCrEnz | −8.497 | <0.001 |
| SCrJaffe | 8.235 | <0.001 | ||
| Age | −0.018 | 0.153 | ||
| ΔeGFREKFC | SCrEnz | −7.684 | <0.001 | |
| SCrJaffe | 7.443 | <0.001 | ||
| Age | −0.019 | 0.097 | ||
Descriptive statistics for patient age and serum creatinine values measured by enzymatic and Jaffe methods_
| Variable: | Age | Female age | Men age | SCrEnzymatic (mg/dL) | SCrJaffe (mg/dL) |
|---|---|---|---|---|---|
| Number | 427 | 213 | 214 | 427 | 427 |
| Min | 42 | 42 | 42 | 0.66 | 0.66 |
| Max | 98 | 98 | 90 | 18.59 | 19.2 |
| Mean/Median | 67 | 66 | 66 | 1.78 | 1.79 |
| SD / IQR | 15 | 6.25 | 11.6 | 1.7 | 2.2 |